French-Swedish Life Science Days 2019
Partnering and investment focus
Business Sweden in cooperation with its strategic partners welcome you to participate in an exclusive investment and partnering meeting.
The conference will gather early stage and highly innovative medtech and biotech companies from Sweden and France, French and Swedish life science investors as well as executives from pharmaceutical companies.
The goal of the conference is to create an arena for French and Swedish players to establish new contacts and to identify business and collaboration opportunities. In order to make this possible this two-day high-level conference will offer:
- One-to-one meetings with investors, pharmaceutical companies and Swedish biotech/medtech companies, who also have the opportunity to book meetings with French life science start-ups to discuss partnerships
- Online booking of meetings
- Your online profile will be visible to all participants
- Panel discussions and presentations on current topics with industry experts
Who will you meet? (Day 1)
Strategic partners
- Vinnova
- Bpifrance
- AstraZeneca
- MSD
- Business Region Göteborg
Who will you meet?
- ANDERA PARTNERS, Denis Dubuy, Investment Manager
- ANGELS SANTÉ, Caroline Saï, Responsible of Operations, Europe Coordinator
- ASTRAZENECA - Dr. David Rosenbaum, Director Medical Affairs Cardiology, Renal and Metabolism
- CENPONTS, Jinlong Hue, Project Manager
- EIFFEL INVESTMENT GROUP, Jean-François Paumelle, Deputy General Director
- EIT Health France, Jean-Marc Bourez, Managing Director
- EIT Health Scandinavia, Erik Forsberg, Managing Director
- INVEST SECURITIES, Jean-Emmanuel Vernay, General Director
- MSD INNOVATION HUB - Phil L'Huillier, Head of Business Development, Europe
- ODDO BHF, Martial Descoutures, Senior Equity Research Analyst Pharma / Biotech
- ODDO BHF, Sébastien Malafosse, Executive Director, Healthcare, Corporate Finance
- SANOFI, Oliver Chao, Head, Emerging Biomedical Sciences, Partnership Responsible
- SEROBA LIFE SCIENCES, Bruno Montanari, Partner
- SOCIÉTÉ GÉNÉRALE CORPORATE & INVESTMENT BANKING, Delphine Le Louët, Director Biotech, Medtech, Small & Mid caps Healthcare
- SOCIÉTÉ GÉNÉRALE CORPORATE & INVESTMENT BANKING, Rodoplphe Besserve, Corporate Finance, Start-ups & French Techs, Head SuFT Advisory
- SOFINNOVA PARTNERS, Representative TBC
Two-day conference
First day, October 1st
The first day is open to Swedish Life Science start-ups, investors, and pharmaceutical companies. The day will serve as a platform for meetings between Swedish Life Science start-ups, investors, and pharmaceutical companies.
Second day, October 2nd
The second day is open to Swedish and French Life Science start-ups. The goal is match-making between Swedish and French Life Science start-ups, with the goal of creating opportunities for EUREKA and Eurostars partnerships. The day offers a unique opportunity for Swedish and French start-ups to launch one-to-one meetings and develop contacts.
For Programmes and Location details, please consult the menu at the top of this web page.
Participation and Registration
For full day program, incl. one-to-one meetings, networking lunch, coffee and closing cocktail
- French investors within the life science industry - free of charge
- For other types of companies other conditions apply, please contact Business Sweden at gilbert.gullberg@business-sweden.se or +33 (0)1 76 53 72 05
Please note that there is a limited number of places available for this event. Once the limit is reached, the organisers reserves the right to close the registration.
Registration: Please register here by uploading your company profile. The registration process will only take a few minutes.
Important deadlines
- 20 September: End of registration
- 21-30 September: Booking of one-to-one meetings
- 1-2 October: Conferece and one-to-one meetings
For all questions and all other matters, please see the Contact page found in the menu at the top of this web page.
For Programmes and Location details, please consult the menu at the top of this web page.
